In cervical cancer, Heeren et al. found differing serum levels of the immunosuppressive tryptophan metabolite l-kynurenine dependent on whether IDO is expressed on tumor cells (high levels of l-kynurenine) or immune cells (low levels of l-kynurenine) [39]. Here, IDO1 is linked to cervical cancer.